ArticleJAMA oncology2023

Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR Phase 2 Nonrandomized Controlled Trial.

Michael F Gensheimer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.